MDxHealth is trading 13.44% up at $0.59 on September 30, 2026; no company-specific announcement explaining the move was found.
- Its 2026 press-release archive lists second-quarter results on August 13 as its latest release.
- Broader markets are higher; Reuters linked the wider risk-on backdrop to cooler-than-expected August PCE inflation and reduced expectations of a near-term rate hike.
- That backdrop may provide context, but available evidence does not establish it as the direct cause of MDxHealth’s gain.